Literature DB >> 22171215

A metastatic jejunal tumor from squamous cell carcinoma of the lung found in an intestinal perforation.

Takayuki Tanaka1, Shigeki Minami, Ryuji Tsutsumi, Takashi Azuma, Shigetoshi Matsuo, Kuniko Abe, Tomayoshi Hayashi, Susumu Eguchi.   

Abstract

An 85-year-old male with advanced squamous cell carcinoma of the lung, who was diagnosed about 10 years prior to his current presentation, suddenly complained of abdominal pain and underwent an abdominal computed tomography scan, which revealed free air and massive ascites. He was admitted to our hospital for acute peritonitis and emergency surgery was performed. During the surgical procedure, a perforation of the jejunum was diagnosed and repaired. He was diagnosed to have a metastatic tumor originating from a squamous cell carcinoma of the lung. He improved and was transferred to the former hospital on the 27th postoperative day. Jejunal metastasis from squamous cell carcinoma of the lung is rare, and the prognosis of peritonitis due to a perforated intestinal metastasis from lung cancer is poor. There have been 10 reports of jejunal metastasis of squamous cell carcinoma of the lung reported in Japan between 2000 and 2011. Therefore, when patients with advanced lung cancer present with acute abdomen, it is necessary to keep in mind the possibility of a gastrointestinal metastatic tumor.

Entities:  

Keywords:  Intestinal metastasis; Lung cancer; Peritonitis

Year:  2011        PMID: 22171215      PMCID: PMC3237110          DOI: 10.1159/000334426

Source DB:  PubMed          Journal:  Case Rep Gastroenterol        ISSN: 1662-0631


Introduction

Lung cancer has a high rate of metastasis, and the malignant potential is high. The most common metastatic sites are the other lung (50%), liver (37%), adrenal gland (31%), bone (29%), kidneys (18%), and brain (12%), but the frequency of metastasis to the digestive tract is rare (2.8–8.8%). Furthermore, in various reports, the rate of metastatic intestinal tumors from lung cancer was about 0.1–3%. The most common histological type resulting in metastasis is large cell carcinoma, followed by adenocarcinoma, small cell carcinoma, and squamous cell carcinoma. A small intestinal metastatic tumor can cause various symptoms, such as obstruction, malabsorption, hemorrhage, and perforation. Therefore, emergency operation may be needed when such symptoms occur. However, the prognosis is extremely poor when intestinal metastasis is found at the condition of perforation. We herein report a rare case of a metastatic jejunal tumor that originated from squamous cell carcinoma of the lung and which was found when the patient developed peritonitis and was treated successfully with surgery.

Case Report

The present case was an 85-year-old male patient with a previous history of squamous cell carcinoma of the lung (T1N0M0 stage Ib) which was diagnosed about 10 years prior to his current presentation. He had received stereotactic irradiation for 3 months, and for 2 years thereafter he remained stable. During a follow-up examination, it was found that the lung tumor had grown and that he had also developed a metastatic bone tumor (T4N1M1 stage IV). He received best supportive care and was admitted to a hospital for pain control. However, while in the hospital, he experienced sudden abdominal pain. He was transferred to our hospital with acute peritonitis. At the time of admission, the patient was 151 cm tall, weighted 43 kg, and his BMI was 18.9 kg/m2. His blood pressure was 126/76 mm Hg with a heart rate of 89 beats/min, a body temperature of 37.5°C, and a SpO2 of 98% on room air. Physical examination revealed slight anemia on conjunctival examination, marked abdominal tenderness, and peritoneal irritation. Laboratory tests revealed a WBC count of 7,500 cells/m3, a hemoglobin level of 8.7 g/dl, a platelet level of 30.0 × 104 cells/m3, an albumin level of 3.4 g/dl, a BUN level of 28.3 mg/dl, a creatinine level of 0.60 mg/dl, and a CRP level of 12.21 mg/dl. His transaminase level was normal. In the coagulation test, the prothrombin time was 88.0% (INR: 1.01). In the blood gas test, the results were indicative of alkalosis, with a pH of 7.522, a PaCO2 of 37.1, a PaO2 of 78.8, a HCO3 of 30.3, and a BE of 7.0. A chest X-ray revealed a large tumor in the right lower lung and multiple small nodules in both lungs. A chest computed tomography (CT) scan revealed the same findings as the chest X-ray. An abdominal CT scan revealed free air and massive ascites in the Douglas fossa (fig. ). An upper gastrointestinal series with water-soluble contrast media showed no obvious areas of perforation. Although the site of perforation was not identified, he was diagnosed with acute peritonitis with gastrointestinal perforation and underwent emergency surgery. During the surgical procedure, a large amount of dirty ascites was found. A perforation was discovered about 70 cm inside the jejunum from Treitz's ligament (fig. ). An intestinal resection of approximately 40 cm was performed. The intraperitoneal cavity was washed with 6,000 ml saline solution and a functional end-to-end anastomosis was performed. After the operation the patient improved gradually. He was transferred to the former hospital on the 27th postoperative day. However, he died about 2 months after having been transferred. The pathological diagnosis of the resected specimen was a metastatic jejunal tumor from a squamous cell carcinoma of the lung (fig. ).

Discussion

Lung cancer has a high rate of metastasis, and the malignant potential is high. The most common metastatic sites are the other lung (50%), liver (37%), adrenal gland (31%), bone (29%), kidneys (18%), and brain (12%), but the frequency of metastasis to the digestive tract is rare (2.8–8.8%) [1, 2, 3]. Furthermore, in various reports, the rate of metastatic intestinal tumors from lung cancer was about 0.1–3% [3, 4]. Metastatic intestinal tumors from lung cancer present with various symptoms. Takeyoshi et al. [5] reported that the clinical presentation of a metastatic intestinal tumor is most commonly a perforation (35.9%), followed by stenosis (27%), intussusception (21.8%), and melena (15.4%) [5, 6, 7, 8]. The present case was found to have a jejunal perforation, and emergency operation was necessary. In a histological examination of gastrointestinal metastatic tumors from lung cancer, Ryo et al. [9] reported that metastasis of lung cancer to the digestive tract (excluding the esophagus) was confirmed by surgery or autopsy in 30 of 1,635 lung cancer patients during a 17-year period, and that the most common histological type of lung cancer was large cell carcinoma (3.7%), followed by adenocarcinoma (2.4%), small cell carcinoma (1.7%), and squamous cell carcinoma (0.7%). In the present case, the histological type was squamous cell carcinoma. The prognosis of metastatic intestinal tumor perforation is especially poor. Metastatic intestinal tumor from lung cancer was demonstrated to occur more often in males than in females, and at a mean age of 64.5 years [10]. The 1-year survival rate in patients who underwent surgery for the perforation was 12% [11]. While the 50% cumulative survival rate for obstruction was about 3 months, that for perforation was about 1.7 months [11]. Since the prognosis of the lung cancer itself is poor and peritonitis further decreases the patient's condition, it was thought that the prognosis of patients who underwent surgery for a metastatic intestinal tumor was especially poor [1, 2, 3, 5]. In the present case, the patient died about 2 months after he was transferred to his former hospital (about 3 months after surgery). Perforation due a metastatic intestinal tumor is thought to be caused by ischemia of the intestinal wall resulting from a blood or tumor thrombus, the necrosis of the intestinal wall as a result of chemotherapy, an increase in the intestinal pressure induced by obstruction, and so on [12]. In the present case, the symptom of obstruction was not present and the patient was not treated with chemotherapy. The mechanism responsible for his perforation was therefore thought to be the following: First, tumor cells from the lung cancer metastasized to the small intestine via the bloodstream. Second, the tumor cells became established in the submucosal layer and started to grow in the new location. Finally, the center of the tumor became relatively ischemic, causing perforation. Because of the advances in chemotherapy and supportive care, the survival of lung cancer patients has been increasing. Therefore, it is necessary to pay attention to the symptoms indicative of a metastatic intestinal tumor, such as obstruction, abdominal pain, melena, nausea and so on. If such symptoms appear, it is thought to be possible to improve a patient's quality of life by locating the metastatic sites with positron emission tomography (PET) and treating them appropriately, including with surgery when indicated. Recently, various reports have shown the usefulness of PET [13, 14, 15]. If we could effectively use PET in such cases, we might be able to more accurately predict the presence of intestinal metastatic tumors. In conclusion, we experienced a rare case of perforation of an intestinal metastatic tumor caused by lung cancer. To our knowledge, the prognosis of metastatic intestinal tumors from lung cancer is very poor, and the survival rate is extremely low. Therefore, when patients with advanced lung cancer develop an acute abdomen, it is necessary to keep in mind the possibility of a gastrointestinal metastatic tumor and to appropriately diagnose and treat the acute abdomen.
  10 in total

1.  Small bowel perforation caused by metastasis from an extra-abdominal malignancy: report of three cases.

Authors:  N Ise; H Kotanagi; M Morii; O Yasui; M Ito; K Koyama; M Sageshima
Journal:  Surg Today       Date:  2001       Impact factor: 2.549

2.  Gastro-intestinal metastasis of primary lung carcinoma: clinical presentations and outcome.

Authors:  Chih-Jen Yang; Jhi-Jhu Hwang; Wang-Yi Kang; Inn-Wen Chong; Tung-Heng Wang; Chau-Chyun Sheu; Jong-Rung Tsai; Ming-Shyan Huang
Journal:  Lung Cancer       Date:  2006-09-27       Impact factor: 5.705

3.  Small bowel metastases from primary carcinoma of the lung.

Authors:  P M McNeill; L D Wagman; J P Neifeld
Journal:  Cancer       Date:  1987-04-15       Impact factor: 6.860

4.  Metastatic pattern in non-resectable non-small cell lung cancer.

Authors:  L E Stenbygaard; J B Sørensen; H Larsen; P Dombernowsky
Journal:  Acta Oncol       Date:  1999       Impact factor: 4.089

5.  Small bowel metastases from primary carcinoma of the lung: clinical findings and outcome.

Authors:  A Berger; C Cellier; C Daniel; C Kron; M Riquet; J P Barbier; P H Cugnenc; B Landi
Journal:  Am J Gastroenterol       Date:  1999-07       Impact factor: 10.864

6.  [Positron emission tomography (PET)-computed tomography (CT) suggesting small intestinal metastasis from lung cancer; report of a case].

Authors:  S Shiono; T Masaoka; T Sato; N Yanagawa
Journal:  Kyobu Geka       Date:  2006-05

Review 7.  A case and review of bowel perforation secondary to metastatic lung cancer.

Authors:  Robert A Garwood; Mark D Sawyer; E J Ledesma; Eugene Foley; Jeffrey A Claridge
Journal:  Am Surg       Date:  2005-02       Impact factor: 0.688

Review 8.  PET imaging in assessing gastrointestinal tumors.

Authors:  Roland Hustinx
Journal:  Radiol Clin North Am       Date:  2004-11       Impact factor: 2.303

9.  Small bowel perforation secondary to metastatic lung carcinoma.

Authors:  R B Leidich; L E Rudolf
Journal:  Ann Surg       Date:  1981-01       Impact factor: 12.969

10.  Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer.

Authors:  Rosemary F Kelly; Thao Tran; Amy Holmstrom; Jozef Murar; Romualdo J Segurola
Journal:  Chest       Date:  2004-04       Impact factor: 9.410

  10 in total
  1 in total

1.  Metastatic squamous cell carcinoma from hand skin causing small bowel obstruction: an unusual case presentation.

Authors:  Ruixin Li; Zihua Chen; Qiaocheng Wen; Zhikang Chen
Journal:  World J Surg Oncol       Date:  2014-05-28       Impact factor: 2.754

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.